212.26
price up icon2.02%   4.20
after-market アフターアワーズ: 224.84 12.58 +5.93%
loading
前日終値:
$208.06
開ける:
$209.71
24時間の取引高:
1.21M
Relative Volume:
1.29
時価総額:
$13.32B
収益:
$4.27B
当期純損益:
$-356.15M
株価収益率:
-35.55
EPS:
-5.9702
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
+4.06%
1か月 パフォーマンス:
+13.54%
6か月 パフォーマンス:
+54.69%
1年 パフォーマンス:
+79.59%
1日の値動き範囲:
Value
$208.41
$212.57
1週間の範囲:
Value
$198.68
$212.57
52週間の値動き範囲:
Value
$97.50
$212.57

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1106)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,890
Name
Twitter
@jazzpharma
Name
次回の収益日
2026-05-05
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
JAZZ icon
JAZZ
Jazz Pharmaceuticals Plc
212.26 13.05B 4.27B -356.15M 1.19B -5.9702
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 109.34B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 74.35B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 50.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 39.78B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.02B 5.36B 287.73M 924.18M 2.5229

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 再開されました Raymond James Outperform
2026-02-27 開始されました Barclays Overweight
2025-11-24 ダウングレード UBS Buy → Neutral
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
May 05, 2026

Jazz Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Top Estimates - Yahoo Finance Singapore

May 05, 2026
pulisher
May 05, 2026

Earnings call transcript: Jazz Pharmaceuticals Q1 2026 earnings beat expectations By Investing.com - Investing.com Canada

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals plc 2026 Q1ResultsEarnings Call Presentation (NASDAQ:JAZZ) 2026-05-05 - Seeking Alpha

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript - Benzinga

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals surges on earnings beat, strong revenue By Investing.com - Investing.com South Africa

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals surges on earnings beat, strong revenue - Investing.com

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surges 3.7% After-Hours on Q1 2026 Revenue and EPS Beat - ChartMill

May 05, 2026
pulisher
May 05, 2026

Jazz: Q1 Earnings Snapshot - wwltv.com

May 05, 2026
pulisher
May 05, 2026

(JAZZ) Jazz Pharmaceuticals Expects Full Year 2026 Revenue Range $4.25B$4.50B, vs. FactSet Est of $4.44B - marketscreener.com

May 05, 2026
pulisher
May 05, 2026

Bruce Cozadd sells 6,000 Jazz (NASDAQ: JAZZ) shares under 10b5-1 plan - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Reports Q1 Revenue $1.07B, vs. FactSet Est of $978.5M - marketscreener.com

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q1 CY2026 Sales - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Posts Q1 Adjusted EPS $6.34 per Share - marketscreener.com

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) swings to Q1 2026 profit on PRV sale - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) posts 19% Q1 revenue growth - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results - PR Newswire

May 05, 2026
pulisher
May 05, 2026

All eyes on Jazz Pharmaceuticals earnings as FDA decision nears By Investing.com - Investing.com Canada

May 05, 2026
pulisher
May 05, 2026

All eyes on Jazz Pharmaceuticals earnings as FDA decision nears - Investing.com

May 05, 2026
pulisher
May 05, 2026

MSN Money - MSN

May 05, 2026
pulisher
May 04, 2026

Jazz Pharmaceuticals stock hits all-time high at 207.49 USD By Investing.com - Investing.com India

May 04, 2026
pulisher
May 04, 2026

Jazz Pharmaceuticals stock hits all-time high at 207.49 USD - Investing.com

May 04, 2026
pulisher
May 04, 2026

Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For - Yahoo Finance

May 04, 2026
pulisher
May 03, 2026

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat

May 03, 2026
pulisher
May 02, 2026

A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Ziihera Priority Review Milestone - simplywall.st

May 02, 2026
pulisher
May 01, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) reports two 6,000-share Rule 144 sales - Stock Titan

May 01, 2026
pulisher
May 01, 2026

JAZZ Forecast, Price Target & Analyst Ratings | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill

May 01, 2026
pulisher
Apr 30, 2026

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Sees Significant Decline in Short Interest - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Vanguard Capital Management reports 5.04% stake in Jazz Pharmaceuticals (NASDAQ: JAZZ) - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Will Ziihera’s Priority Review in First-Line HER2-Positive Gastric Cancer Shift Jazz Pharmaceuticals’ (JAZZ) Narrative? - simplywall.st

Apr 30, 2026
pulisher
Apr 30, 2026

Pictet Asset Management Holding SA Sells 33,547 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Apr 30, 2026
pulisher
Apr 29, 2026

M&T Bank Corp Purchases New Shares in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Apr 29, 2026
pulisher
Apr 28, 2026

US Cannabis Market Report Analysis Report 2026-2034 Featuring Canopy Growth, Tilray Brands, Curaleaf, Aurora Cannabis, Jazz Pharma, GTI, Trulieve, Cresco Labs, Organigram Global, TerrAscend - Yahoo Finance

Apr 28, 2026
pulisher
Apr 28, 2026

Jazz Pharmaceuticals (JAZZ) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Apr 28, 2026
pulisher
Apr 28, 2026

Market Driver Insights: The Impact of Recent Developments on the Erwinaze/Spectrila Market - openPR.com

Apr 28, 2026
pulisher
Apr 27, 2026

FDA accepts Jazz Pharma filing for Ziihera in gastric cancer By Investing.com - Investing.com South Africa

Apr 27, 2026
pulisher
Apr 27, 2026

FDA accepts Jazz Pharma filing for Ziihera in gastric cancer - Investing.com UK

Apr 27, 2026
pulisher
Apr 27, 2026

Wells Fargo Maintains Jazz Pharmaceuticals (JAZZ) Overweight Recommendation - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

How ASCO Phase 3 Oncology Data May Reshape Jazz Pharmaceuticals' (JAZZ) Investment Narrative - Yahoo Finance

Apr 27, 2026
pulisher
Apr 27, 2026

Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks - Yahoo Finance

Apr 27, 2026
pulisher
Apr 27, 2026

Jazz Pharmaceuticals announces FDA acceptance and Priority Review of supplemental biologics license application for Ziihera - marketscreener.com

Apr 27, 2026
pulisher
Apr 27, 2026

Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA - PR Newswire

Apr 27, 2026
pulisher
Apr 27, 2026

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with a 14.76% Upside Potential - DirectorsTalk Interviews

Apr 27, 2026
pulisher
Apr 26, 2026

Jazz Pharmaceuticals enters exclusive licensing deal with Saniona - msn.com

Apr 26, 2026
pulisher
Apr 26, 2026

Universal Beteiligungs und Servicegesellschaft mbH Has $15.32 Million Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Apr 26, 2026
pulisher
Apr 25, 2026

Polaris Capital Management LLC Sells 81,000 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Apr 25, 2026
pulisher
Apr 25, 2026

Jazz Pharmaceuticals Executive Compensation Program 2025: Structure, Philosophy, and Key Features Explained - Minichart

Apr 25, 2026
pulisher
Apr 24, 2026

Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference - 富途牛牛

Apr 24, 2026
pulisher
Apr 24, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) details 2025 pay, board and pipeline - Stock Titan

Apr 24, 2026
pulisher
Apr 24, 2026

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Oncology Data, Cannabis Shift And Modeyso Royalty News - simplywall.st

Apr 24, 2026

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):